X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/biotech/scandion-flunks-part-2-its-phase-2-trial-due-low-tumor-reduction-rate
https://news.cision.com/scandion-oncology-a-s/r/scandion-oncology-receives-approval-for-initiating-the-corist-part-2-trial,c3410221
https://news.cision.com/scandion-oncology-a-s/r/scandion-oncology-receives-german-trial-approval-for-pantax-ib-study,c3404242
https://www.pharmacompass.com/pdf/news/scandion-oncology-announces-results-from-the-next-evaluable-chemo-resistant-1598628935.pdf
https://news.cision.com/scandion-oncology-a-s/r/scandion-oncology-drug-sco-101-potentiates-the-effect-of-chemotherapy-in-the-first-cohort-of-patient,c3162348
https://news.cision.com/scandion-oncology-a-s/r/clinical-development-plans-for-sco-101,c3066414
Market Place
Share 
